Congress approved the fiscal year 2022 omnibus spending package on March 11. It included great news for the childhood cancer community: the STAR Act will
[vc_row][vc_column][vc_column_text] Assorted news from last week: Steven E. Lipshultz, MD, is senior author on a new study that shows healthier hearts in long-term childhood cancer
Assorted news from last week: The story of Moonshot4Kids meets the White House Moonshot: CAC2 Member Janet Demeter (Jack’s Angels) encourages medical research investment into
Assorted news from last week: Study finds no link between Body Mass Index and thyroid cancer in teens with nodules. When acute myeloid leukemia (AML)
Assorted news from last week: Dr. Brigitte Widemann appointed as the Special Advisor to NCI Director Ned Sharpless for childhood cancer. When Jace Ward joined a
[vc_row][vc_column][vc_column_text] Assorted news from last week: The White House announced the reigniting of the Cancer Moonshot on February 2. Two prominent items related to the
[vc_row][vc_column][vc_column_text] Assorted news from last week: Retinoblastoma treatment outcomes have improved globally over the past four decades but large disparities persist between higher-income and lower-income
Assorted news from the last two weeks: Adolescents and young adult cancer survivors are more likely to have psychological distress and additional annual medical expenses
Assorted news from the last two weeks: Children with chronic health conditions, including cancer, and those with special education needs, should receive more help with
Assorted news from the last two weeks: The FDA has granted rare pediatric disease designation to IMX-110 for the treatment of rhabdomyosarcoma, a life-threatening cancer
